Platelets in Sepsis: An Update on Experimental Models and Clinical Data

Area of Science:

• Hematology and Immunology
• Sepsis Pathophysiology
• Inflammatory Disease Mechanisms

Background:

• Platelets are critical in hemostasis and inflammatory diseases, notably sepsis.
• Sepsis involves a dysregulated host response to infection, causing organ dysfunction.
• Platelet count and activation correlate with sepsis severity and patient survival.

Purpose of the Study:

• To review the current understanding of platelet contributions to sepsis severity and outcomes.
• To explore the immunomodulatory functions of platelets in various sepsis models.
• To highlight differences in platelet receptors between mice and humans.

Main Methods:

• Review of experimental in vivo models, primarily in mice, to study sepsis.
• Analysis of data correlating platelet count and activation with sepsis outcomes.
• Comparison of platelet receptor expression and function in murine and human sepsis models.

Main Results:

• Platelet dysfunction is a key feature of sepsis-induced tissue injury.
• Thrombocytopenia is an independent risk factor for mortality in sepsis.
• Platelet immunomodulatory function varies based on the experimental model, infection type, and timing.

Conclusions:

• Platelets play a complex role in sepsis development and progression.
• Understanding platelet mechanisms in inflammation is crucial for managing thrombotic and bleeding complications.
• Limitations exist in using animal models to fully recapitulate human platelet functions in sepsis.